Life Healthcare Group Holdings Limited has unveiled plans to invest R2.3 billion in capital expenditure for FY2025 as part of its growth strategy, alongside reporting robust interim results for the six months ended 31 March 2025.
Financial and Operational Highlights
-
Revenue up 8.1% to R12.1 billion, driven by higher patient volumes and improved tariffs
-
Normalised earnings per share (NEPS) up 9.1% to 49.0 cents
-
Interim dividend increased by 10.5% to 21.0 cents per share
-
Paid patient days (PPDs) grew by 2.0%, with occupancy rising to 68.6%
-
R2 billion cash generated from operations, supporting expansion plans
R2.3bn Investment in Strategic Growth
The Group’s R2.3 billion capital expenditure plan for 2025 includes:
-
58 new acute hospital beds and 24 rehabilitation beds
-
One new cathlab and vascular lab
-
Two additional PET-CT diagnostic sites (expected H2-2025)
-
Completion of two imaging transactions
-
New hospital development in Paarl
Peter Wharton-Hood, CEO of Life Healthcare, said: “Our strong operational performance enables us to reinvest in expanding healthcare access. The R2.3bn investment will enhance capacity, modernise facilities, and support long-term growth across Southern Africa.”
Solid Financial Performance
Pieter van der Westhuizen, CFO, highlighted the Group’s financial resilience: “With R2bn cash generated from operations and net debt well within covenants, we are well-positioned to fund our expansion while rewarding shareholders with a 10.5% higher dividend.”
Progress on LMI Disposal
The sale of Life Molecular Imaging (LMI) remains on track for H2-2025, reinforcing the group’s focus on core hospital and diagnostic services.
Outlook: Sustained Growth and Efficiency
Life Healthcare remains committed to:
-
Improving occupancy and operational efficiency
-
Expanding high-demand healthcare services
-
Delivering value to patients and shareholders
Wharton-Hood concluded: “We thank our teams for their dedication in driving these results. Our investment plan ensures Life Healthcare remains a leader in quality healthcare delivery.”
With strong financials and strategic expansion underway, Life Healthcare is poised for sustained growth in 2025 and beyond.
